Free Trial

Ironwood Pharmaceuticals (IRWD) Competitors

Ironwood Pharmaceuticals logo
$0.82 -0.05 (-5.49%)
Closing price 04:00 PM Eastern
Extended Trading
$0.82 +0.00 (+0.05%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRWD vs. ABBV, LXRX, MYGN, EBS, RIGL, XOMA, VSTM, VNDA, CBIO, and CDXS

Should you be buying Ironwood Pharmaceuticals stock or one of its competitors? The main competitors of Ironwood Pharmaceuticals include AbbVie (ABBV), Lexicon Pharmaceuticals (LXRX), Myriad Genetics (MYGN), Emergent Biosolutions (EBS), Rigel Pharmaceuticals (RIGL), XOMA Royalty (XOMA), Verastem (VSTM), Vanda Pharmaceuticals (VNDA), Crescent Biopharma (CBIO), and Codexis (CDXS). These companies are all part of the "medical" sector.

Ironwood Pharmaceuticals vs. Its Competitors

AbbVie (NYSE:ABBV) and Ironwood Pharmaceuticals (NASDAQ:IRWD) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

70.2% of AbbVie shares are owned by institutional investors. 0.3% of AbbVie shares are owned by company insiders. Comparatively, 12.7% of Ironwood Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

AbbVie presently has a consensus price target of $211.29, indicating a potential upside of 10.71%. Ironwood Pharmaceuticals has a consensus price target of $4.78, indicating a potential upside of 483.62%. Given Ironwood Pharmaceuticals' higher probable upside, analysts clearly believe Ironwood Pharmaceuticals is more favorable than AbbVie.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AbbVie
0 Sell rating(s)
8 Hold rating(s)
16 Buy rating(s)
3 Strong Buy rating(s)
2.81
Ironwood Pharmaceuticals
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

AbbVie has higher revenue and earnings than Ironwood Pharmaceuticals. Ironwood Pharmaceuticals is trading at a lower price-to-earnings ratio than AbbVie, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AbbVie$57.37B5.88$4.28B$2.3581.21
Ironwood Pharmaceuticals$351.41M0.38$880K-$0.20-4.10

AbbVie has a net margin of 7.31% compared to Ironwood Pharmaceuticals' net margin of -9.89%. AbbVie's return on equity of 412.03% beat Ironwood Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
AbbVie7.31% 412.03% 13.11%
Ironwood Pharmaceuticals -9.89%-1.87%-3.93%

AbbVie has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Comparatively, Ironwood Pharmaceuticals has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500.

In the previous week, AbbVie had 72 more articles in the media than Ironwood Pharmaceuticals. MarketBeat recorded 76 mentions for AbbVie and 4 mentions for Ironwood Pharmaceuticals. AbbVie's average media sentiment score of 1.15 beat Ironwood Pharmaceuticals' score of 0.96 indicating that AbbVie is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AbbVie
53 Very Positive mention(s)
5 Positive mention(s)
15 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Ironwood Pharmaceuticals
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

AbbVie beats Ironwood Pharmaceuticals on 15 of the 17 factors compared between the two stocks.

Get Ironwood Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRWD vs. The Competition

MetricIronwood PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$140.33M$2.52B$5.70B$9.48B
Dividend YieldN/A1.76%4.59%3.99%
P/E Ratio-4.109.1227.9019.95
Price / Sales0.38746.51442.18102.66
Price / Cash17.53166.2336.5558.97
Price / Book-0.445.228.635.90
Net Income$880K$30.99M$3.24B$258.42M
7 Day Performance3.64%4.29%3.22%1.94%
1 Month Performance12.92%13.40%10.72%12.02%
1 Year Performance-87.68%0.59%34.94%20.81%

Ironwood Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRWD
Ironwood Pharmaceuticals
4.3455 of 5 stars
$0.82
-5.5%
$4.78
+483.6%
-87.2%$140.33M$351.41M-4.10220News Coverage
ABBV
AbbVie
4.8796 of 5 stars
$184.77
-2.4%
$211.29
+14.4%
+9.9%$334.31B$56.33B78.6255,000Positive News
Upcoming Earnings
LXRX
Lexicon Pharmaceuticals
2.5735 of 5 stars
$1.23
flat
$3.67
+198.1%
-45.5%$444.64M$31.08M0.00140Upcoming Earnings
MYGN
Myriad Genetics
4.4841 of 5 stars
$4.45
-0.4%
$14.38
+223.2%
-83.1%$412.03M$837.60M0.002,700
EBS
Emergent Biosolutions
4.3305 of 5 stars
$6.93
+0.0%
$14.33
+106.8%
-38.7%$376.14M$1.04B-2.562,420Positive News
RIGL
Rigel Pharmaceuticals
3.2182 of 5 stars
$19.59
+4.2%
$36.40
+85.8%
+100.1%$336M$179.28M9.08160Positive News
XOMA
XOMA Royalty
3.9286 of 5 stars
$25.48
-0.7%
$69.50
+172.8%
-10.2%$307.19M$28.49M0.0010
VSTM
Verastem
3.5304 of 5 stars
$5.10
-1.2%
$13.38
+162.3%
+49.0%$283.54M$10K0.0050
VNDA
Vanda Pharmaceuticals
4.5983 of 5 stars
$4.66
-2.5%
$16.50
+254.1%
-23.2%$281.71M$198.77M-6.21290News Coverage
Upcoming Earnings
CBIO
Crescent Biopharma
3.3374 of 5 stars
$13.20
-1.0%
$25.67
+94.4%
N/A$260.79M$10K-0.2950
CDXS
Codexis
2.9193 of 5 stars
$2.84
+0.7%
$11.00
+287.3%
-9.8%$233.62M$59.35M-2.87250

Related Companies and Tools


This page (NASDAQ:IRWD) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners